FOLETTA MARK G 4
Research Summary
AI-generated summary
Dexcom (DXCM) Director Mark G. Foletta Gifts 5,731 Shares to Family Trust
What Happened
Mark G. Foletta, a director of Dexcom, recorded a gift transaction on May 8, 2026 involving 5,731 shares. The Form 4 shows a disposition of 5,731 shares at $0.00 and a simultaneous acquisition of 5,731 shares at $0.00 — reflecting a transfer by gift rather than a market sale or purchase. The reported dollar value is $0 because the shares were gifted.
Key Details
- Transaction date: 2026-05-08; Form 4 filed: 2026-05-11 (filed within the typical 2-business-day window).
- Shares transferred: 5,731 shares (disposed from direct ownership and acquired by the trust) at $0.00 per share.
- Shares owned after transaction: not specified in the provided summary of the filing.
- Footnotes: F1 — shares moved from direct ownership to the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust upon vesting of previously awarded restricted stock units; F2 — the shares are held by that trust, for which the reporting person is a trustee.
- Transaction code: G = Gift.
Context
This was an internal transfer/gift tied to the vesting of previously awarded RSUs, not an open-market trade. Gifts and transfers into trusts are administrative and estate-planning moves and do not necessarily indicate the insider’s view of the company’s stock price.